The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Medifast Inc

NYSE: MED
Last

(U.S.) $37.11

Today's change-0.57 -1.51%
Updated September 29 3:23 PM EDT. Delayed by at least 15 minutes.
 

Medifast Inc

NYSE: MED
Last

(U.S.) $37.11

Today's change-0.57 -1.51%
Updated September 29 3:23 PM EDT. Delayed by at least 15 minutes.

Medifast Inc crosses below 20-day moving average

Medifast Inc is sharply lower today, dropping (U.S.)$0.57 or 1.51% to (U.S.)$37.11 and crossing below its 20-day moving average. Shares have lost 3.26% over the last five days, but have gained 22.15% over the last year to date. This security has outperformed the S&P 500 by 21.58% during the last year.

Key company metrics

  • Open(U.S.) $37.49
  • Previous close(U.S.) $37.68
  • High(U.S.) $37.52
  • Low(U.S.) $37.09
  • Bid / Ask(U.S.) $37.06 / (U.S.) $37.10
  • YTD % change+22.15%
  • Volume49,810
  • Average volume (10-day)150,107
  • Average volume (1-month)97,056
  • Average volume (3-month)123,844
  • 52-week range(U.S.) $26.14 to (U.S.) $39.16
  • Beta0.65
  • Trailing P/E26.13×
  • P/E 1 year forward20.26×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.00
  • Dividend yield2.69%
  • Trailing EPS(U.S.) $1.42
Updated September 29 3:23 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.26%

Based on its net profit margin of 6.26%, Medifast Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.20%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Food Processing

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue71726166
Total other revenue--------
Total revenue71726166
Gross profit53534549
Total cost of revenue18191617
Total operating expense66665658
Selling / general / administrative48474041
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income5668
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax5668
Income after tax3445
Income tax, total2223
Net income3446
Total adjustments to net income--------
Net income before extra. items3445
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3445
Inc. avail. to common incl. extra. items3446
Diluted net income3446
Dilution adjustment----0--
Diluted weighted average shares12121212
Diluted EPS excluding extraordinary itemsvalue per share0.290.360.330.45
Dividends per sharevalue per share0.250.250.250.00
Diluted normalized EPSvalue per share0.290.360.330.45